Overview

Menorrhagia Study in Women With Treatment-resistant Menorrhagia

Status:
Completed

Trial end date:
2004-01-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to explore effects of the investigational product for the treatment of treatment-resistant menorrhagia without organic cause.

Phase:

Phase 2

Details

Lead Sponsor:

Bayer

Collaborator:

TAP Pharmaceutical Products Inc.